title: First clinical experience with an adjunctive hemoperfusion device designed specifically to remove beta 2-microglobulin in hemodialysis.
authors.affiliation: Renal Research Institute, New York, N.Y., USA. cronco@goldnet.it
authors.forename: C
authors.initials: C
authors.lastname: Ronco
authors.forename: A
authors.initials: A
authors.lastname: Brendolan
authors.forename: J F
authors.initials: JF
authors.lastname: Winchester
authors.forename: E
authors.initials: E
authors.lastname: Golds
authors.forename: J
authors.initials: J
authors.lastname: Clemmer
authors.forename: H D
authors.initials: HD
authors.lastname: Polaschegg
authors.forename: T E
authors.initials: TE
authors.lastname: Muller
authors.forename: V
authors.initials: V
authors.lastname: Davankov
authors.forename: M
authors.initials: M
authors.lastname: Tsyurupa
authors.forename: L
authors.initials: L
authors.lastname: Pavlova
authors.forename: M
authors.initials: M
authors.lastname: Pavlov
authors.forename: G
authors.initials: G
authors.lastname: La Greca
authors.forename: N W
authors.initials: NW
authors.lastname: Levin
mesh_terms: D000328:Adult; D004867:Equipment Design; D006464:Hemoperfusion / Q000295:instrumentation*; D006801:Humans; D008297:Male; D008875:Middle Aged; D006435:Renal Dialysis; D001613:beta 2-Microglobulin / Q000302:isolation & purification*
chemical_list: D001613:beta 2-Microglobulin